The aims of this study were to confirm the oncogenic role of G6PD in ccRCC and unravels novel mechanisms involving Cyclin E1 and MMP9 in G6PD-mediated ccRCC progression. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.